Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1555979rdf:typepubmed:Citationlld:pubmed
pubmed-article:1555979lifeskim:mentionsumls-concept:C0002475lld:lifeskim
pubmed-article:1555979lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:1555979lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:1555979lifeskim:mentionsumls-concept:C0851346lld:lifeskim
pubmed-article:1555979lifeskim:mentionsumls-concept:C0681828lld:lifeskim
pubmed-article:1555979lifeskim:mentionsumls-concept:C1513371lld:lifeskim
pubmed-article:1555979pubmed:issue5lld:pubmed
pubmed-article:1555979pubmed:dateCreated1992-5-7lld:pubmed
pubmed-article:1555979pubmed:abstractTextAn examination of the effects of radiation combined with either 5-fluorouracil, Mitomycin C, or both drugs in vitro has been made using a mouse squamous tumor cell line SCC VIITo and cell viability as an endpoint. Depending on how the survival endpoint was calculated, the interaction of 5-fluorouracil, Mitomycin C, or 5-fluorouracil plus Mitomycin C with radiation was greater than additive (plating efficiency) or only additive (viable cells per flask). These results suggest that the cytostatic effect of these drugs may be an important aspect of their action clinically.lld:pubmed
pubmed-article:1555979pubmed:languageenglld:pubmed
pubmed-article:1555979pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555979pubmed:citationSubsetIMlld:pubmed
pubmed-article:1555979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555979pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1555979pubmed:statusMEDLINElld:pubmed
pubmed-article:1555979pubmed:issn0360-3016lld:pubmed
pubmed-article:1555979pubmed:authorpubmed-author:RauthA MAMlld:pubmed
pubmed-article:1555979pubmed:authorpubmed-author:DobrowskyWWlld:pubmed
pubmed-article:1555979pubmed:authorpubmed-author:DobrowskyEElld:pubmed
pubmed-article:1555979pubmed:issnTypePrintlld:pubmed
pubmed-article:1555979pubmed:volume22lld:pubmed
pubmed-article:1555979pubmed:ownerNLMlld:pubmed
pubmed-article:1555979pubmed:authorsCompleteYlld:pubmed
pubmed-article:1555979pubmed:pagination875-80lld:pubmed
pubmed-article:1555979pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:meshHeadingpubmed-meshheading:1555979-...lld:pubmed
pubmed-article:1555979pubmed:year1992lld:pubmed
pubmed-article:1555979pubmed:articleTitleMode of interaction of 5-fluorouracil, radiation, and mitomycin C: in vitro studies.lld:pubmed
pubmed-article:1555979pubmed:affiliationDivision of Experimental Therapeutics, Ontario Cancer Institute, Toronto, Canada.lld:pubmed
pubmed-article:1555979pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1555979pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:1555979pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed